These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 19627007)

  • 1. [Effect of ginsenoside Rgl on the expression of TNF-alpha and MCP-1 in rats with diabetic nephropathy].
    Zhang LN; Xie XS; Zuo C; Fan JM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):466-71. PubMed ID: 19627007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of ginsenoside Rg1 on streptozocin-induced diabetic nephropathy in rats].
    Ma X; Xie X; Zuo C; Fan J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Apr; 27(2):342-7. PubMed ID: 20481316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of retinoic acid in experimental diabetic nephropathy.
    Han SY; So GA; Jee YH; Han KH; Kang YS; Kim HK; Kang SW; Han DS; Han JY; Cha DR
    Immunol Cell Biol; 2004 Dec; 82(6):568-76. PubMed ID: 15550114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.
    Zhang Y; Chen B; Hou XH; Guan GJ; Liu G; Liu HY; Li XG
    Chin Med J (Engl); 2007 Jun; 120(11):988-95. PubMed ID: 17624267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
    Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
    Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of a poly-phytocompound on early stage nephropathy secondary to experimentally-induced diabetes.
    Marotta F; Harada M; Dallah ED; Yadav H; Solimene U; Di Lembo S; Minelli E; Jain S; Chui DH
    J Biol Regul Homeost Agents; 2010; 24(1):41-9. PubMed ID: 20385070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy.
    Li JJ; Lee SH; Kim DK; Jin R; Jung DS; Kwak SJ; Kim SH; Han SH; Lee JE; Moon SJ; Ryu DR; Yoo TH; Han DS; Kang SW
    Am J Physiol Renal Physiol; 2009 Jul; 297(1):F200-9. PubMed ID: 19369290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
    Wang S; Li Y; Huang YJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relation between bone matrix proteins and monocyte chemoattractant protein-1 in renal small artery in diabetic nephropathy rats].
    Zhao AJ; Huang SM; Ou ST; Liu F; Chen ZJ; Hu ZX; Tang WX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):414-9. PubMed ID: 22812249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of tacrolimus on podocytes in early diabetic nephropathy in rats.
    Peng T; Chang X; Wang J; Zhen J; Yang X; Hu Z
    Mol Med Rep; 2017 May; 15(5):3172-3178. PubMed ID: 28339051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats.
    Yu WM; Wang H; Ren XJ; Liu JP; Wang JY
    Nephrology (Carlton); 2012 May; 17(4):380-9. PubMed ID: 22243699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression.
    Gui D; Huang J; Guo Y; Chen J; Chen Y; Xiao W; Liu X; Wang N
    Cytokine; 2013 Mar; 61(3):970-7. PubMed ID: 23434274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of diabetic nephropathy by Chaihuang-Yishen granule through anti-inflammatory mechanism in streptozotocin-induced rat model of diabetics.
    Zhang H; Zhao T; Gong Y; Dong X; Zhang W; Sun S; Wang H; Gu Y; Lu X; Yan M; Li P
    J Ethnopharmacol; 2014; 151(1):556-64. PubMed ID: 24269779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
    Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
    Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of necrostatin-1 on expression of liver monocyte chemotactic protein-1 in septic rats].
    Fan L; Li Z; Fan Z; Wang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):262-6. PubMed ID: 29917343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of irbesartan on renal hypertrophy and thickening of glomerular basement-membrane in streptozotocin-induced diabetic rats].
    Liu BC; Luo DD; Sun J; Ma KL; Ruan XZ
    Zhonghua Nei Ke Za Zhi; 2003 May; 42(5):320-3. PubMed ID: 12882713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of iRhom-2/Tumor Necrosis Factor-α Converting Enzyme Pathway and Oxidative Stress Protects the Renal Injury with Anemonin in Streptozotocin-Induced Diabetic Nephropathy Neonatal Rat Model.
    Qiao L; Liu Y; Li C; Ge J; Li T
    Pharmacology; 2019; 104(5-6):258-266. PubMed ID: 31344701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
    Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
    J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
    Wang ZS; Xiong F; Xie XH; Chen D; Pan JH; Cheng L
    BMC Nephrol; 2015 Mar; 16():44. PubMed ID: 25886386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
    Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C
    Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.